Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 14/20 | 0.64 |
| ▸ | F10 | P00742 | 3/20 | 0.62 |
| ▸ | F2 | P00734 | 5/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.61 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4588318 | 0.84 | F7 (0.66) | F7F10F2CNR1 | |
| SCHEMBL13714617 | 0.79 | F7 (0.65) | F7F10F2 | |
| SCHEMBL5154948 | 0.79 | ST14 (0.44) | F7F2HDAC1HDAC2ST14 | |
| SCHEMBL4426386 | 0.79 | F7 (0.64) | F7F10F2ST14 | |
| SCHEMBL4419447 | 0.78 | F7 (1.00) | F7F10F2 | |
| SCHEMBL4420144 | 0.77 | F7 (1.00) | F7F10F2CNR1 | |
| SCHEMBL236558 | 0.77 | F7 (1.00) | F7F10F2 | |
| SCHEMBL235788 | 0.76 | F7 (1.00) | F7F10F2 | |
| SCHEMBL13936352 | 0.76 | F7 (1.00) | F7F10F2 | |
| Hydrochloric Acid SCHEMBL234684 | 0.76 | F7 (0.98) | F7F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656158-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | Novo Nordisk Health Care AG (CH) | 2006-05-17 | — | — | EP | claimed |
| WO-2005016365-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTH CARE AG (CH) | 2005-02-24 | — | — | WO | claimed |
| EP-1656158-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | Novo Nordisk Health Care AG (CH) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005016365-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTH CARE AG (CH) | 2005-02-24 | — | — | WO | disclosed |